PDLIM7 and extranodal nasal NK/T cell lymphoma: A case series involving 10 NKTCL patients successfully utilized in vitro expanded antigen-specific CTLs against the EBV proteins LMP-1 and LMP-2a in a cohort of patients with lymphomas expressing EBV latent proteins, including patients with NKTCL (200).